Predictive biomarkers for the efficacy of nivolumab as ≥ 3(rd)-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial

PURPOSE: The phase 3 ATTRACTION-2 study demonstrated that nivolumab monotherapy improved survival compared to placebo in patients with pretreated advanced gastric cancer (AGC). However, the efficacy of nivolumab seems to be limited to a subset of patients. MATERIALS AND METHODS: The predictive value...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa Hoon, Ryu, Min-Hee, Park, Young Soo, Ma, Jungeun, Lee, Sun Young, Kim, Deokhoon, Kang, Yoon-Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994342/
https://www.ncbi.nlm.nih.gov/pubmed/35397540
http://dx.doi.org/10.1186/s12885-022-09488-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994342/
https://www.ncbi.nlm.nih.gov/pubmed/35397540
http://dx.doi.org/10.1186/s12885-022-09488-2

Ejemplares similares